Literature DB >> 6174467

In vitro augmentation of natural killing activity by OK-432.

A Uchida, M Micksche.   

Abstract

OK-432, a streptococcal preparation, augmented the natural killing (NK) activity of peripheral blood lymphocytes of normal donors and cancer patients against both NK sensitive and resistant human target cells in vitro. The enhancement of NK activity was evident after 4 h pretreatment and maximum by 16-24 h. The manifestation of OK-432 induced augmentation required active cell metabolism, RNA and protein synthesis but no DNA synthesis of lymphocytes. The supernatants produced by OK-432 stimulated lymphocyte cultures had no enhancing substance nor interferon. Anti-interferon antibodies did not inhibit boosting activity of OK-432. Large granular lymphocytes were involved in both spontaneous and OK-432 induced cytotoxic activity. The proportion of lymphocytes conjugating to target cells was not changed by OK-432. These results suggest that OK-432 augments cytotoxic activity of large granular lymphocytes having ability to recognize target cells independent of interferon induction.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6174467     DOI: 10.1016/0192-0561(81)90032-1

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  21 in total

1.  Immunoregulatory effects of sizofiran (SPG) on lymphocytes and polymorphonuclear leukocytes.

Authors:  K Yoneda; E Ueta; T Yamamoto; T Osaki
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

2.  Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.

Authors:  T Wada; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-06

3.  Inhibition of in vitro LAK generation by OK-432.

Authors:  M Yagita; E A Grimm
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Proliferative responses of peripheral blood mononuclear cells from psoriatic patients to T lymphocyte-stimulating cytokines (IL-2, IL-3, IL-4, and granulocyte-macrophage colony-stimulating factor) and OK-432.

Authors:  S Aiba; H Tagami
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

5.  Induction of activated natural killer cells from murine spleen cells primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.

Authors:  H Yamaue; M Katsumi; K Tabuse; Y Tabuse; K Kuribayashi; T Nishihara; K Saito
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

6.  Induction of natural killer cell activity by inactivated Candida albicans in mice.

Authors:  P Marconi; L Scaringi; L Tissi; M Boccanera; F Bistoni; E Bonmassar; A Cassone
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Effect of a glucan, sizofiran, on natural-killer activity of 5-fluorouracil-treated murine bone marrow cells.

Authors:  Y Tsuchiya; M Matsutani; M Inoue; S Sato; T Asano; M Yajima
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

8.  Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.

Authors:  X L Huang; Z Fan; T Murayama; C Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

9.  Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432.

Authors:  E Yanagawa; A Uchida; M Micksche
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.

Authors:  H Yamaue; H Tanimura; M Iwahashi; M Tani; T Tsunoda; K Tabuse; K Kuribayashi; K Saito
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.